Empathic Communication Skills (ECS) Training
Empathic Communication Skills Training to Reduce Lung Cancer Stigma
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 100 Years
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: Site Eligibility * Employs at least 15 FTE OCPs (i.e., oncologists, nurse practitioners and physician assistants) as per self report * Reports a clinic volume of at least 20 new lung cancer patients per month as per self report OCP Participant Eligibility * OCPs who are thoracic oncology physicians (radiologists, medical oncologists, pulmonologists, and surgeons), NPs, or PAs and currently treating lung cancer patients, as per self-report; * OCP conducts consultations with lung cancer patients, as per self-report; * OCP sees at least 1 lung cancer patient per week, as per self-report; Patient Eligibility * Patient under the care of a participating OCP as per self report; * English and/or Spanish speaking; * In general, which language do you prefer to receive your medical care, English/Spanish/both English and Spanish Equally? * If English, treat as fluent in English, no additional language questions * If Spanish, treat as fluent in Spanish, no additional language questions * If both English and Spanish equally, ask the follow-up questions and go with whichever language is endorsed as best. If endorsed equally, assign to category patient prefers * How well do you speak English? Not at all/ Not well/Well/Very well * How well do you speak Spanish? Not at all/Not well/Well/Very well * Is at least 18 years of age as per self report; * Has a history of suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note; * Is a former or current smoking as per self report; * Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report Exclusion Criteria: Patient Exclusion * Individuals of impaired decision-making capacity as per a clinician's judgment or as documented in the EMR. Site and OCP Exclusion * None
Study sites (12)
CA
- Providence St. Joseph Health (Data Collection Only) · Irvine, CA 92612More trials in Irvine
FL
- BAPTIST ALLIANCE - MCI (Data Collection Only) · Miami, FL 33143Ian Bostock, MD · Study contact · 786-596-2000More trials in Miami
IL
- Advocate Health Care Network · Libertyville, IL 60048Michael Breen, MD · Study contact · 847-367-6781More trials in Libertyville
KY
- University of Kentucky (Data Collection Only) · Lexington, KY 40536-0093More trials in Lexington
MI
- Munson Healthcare (Data Collection Only) · Traverse City, MI 49684More trials in Traverse City
NJ
- Hackensack Meridian Health (Data collection only) · Hackensack, NJ 07601David Greenberg, MD · Study contact · 551-996-8704More trials in Hackensack
NY
- Roswell Park Cancer Institute (Data Collection Only) · Buffalo, NY 14263-0001Elisabeth Dexter, MD · Study contact · 716-845-2300More trials in Buffalo
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) · New York, NY 10065Smita Banerjee, PhD · Study contact · 646-888-0011More trials in New York
PA
- Virtua Health (Data Collection Only) · Philadelphia, PA 08060More trials in Philadelphia
- University of Pennsylvania (Data Collection Only) · Philadelphia, PA 19104-4283Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP · Study contact · (215) 615-5858More trials in Philadelphia
- Fox Chase Cancer Center (Data Collection Only) · Philadelphia, PA 19111Linda Fleisher, PhD, MPH · Study contact · 215-728-4066More trials in Philadelphia
VA
- Chesapeake Regional Healthcare (Data Collection Only) · Chesapeake, VA 23320Stephen Noble, MD · Study contact · 757-842-4499More trials in Chesapeake